Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease.
about
Endothelium-dependent contractions and endothelial dysfunction in human hypertensionN-nitro L-arginine causes coronary vasoconstriction and inhibits endothelium-dependent vasodilatation in anaesthetized greyhoundsOverview of the Acetylcholine Spasm Provocation TestAspirin and endothelial function in hypertensionEndothelial dysfunction: a comprehensive appraisal.Calf and forearm blood flow in hypercholesterolemic patientsAging and vascular endothelial function in humansEndothelium-dependent relaxations in the aorta from K(2p)6.1 knockout miceNoninvasive assessment of coronary vasodilation using cardiovascular magnetic resonance in patients at high risk for coronary artery disease.Invasive assessment of the coronary circulation: intravascular ultrasound and Doppler.Nitric oxide synthase-dependent vasodilation of human subcutaneous arterioles correlates with noninvasive measurements of endothelial function.Adaptation of myocardial blood flow to increased metabolic demand is not dependent on endothelial vasodilators in the rat heart.Paradoxical increase in coronary flow velocity after termination of acetylcholine infusion is a marker of the impaired vasodilatation at coronary microvessels in patients with angina and normal coronary arteries.Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia.Lipid-lowering and skin vascular responses in patients with hypercholesterolaemia and peripheral arterial obstructive disease.End organ protection by calcium-channel blockers.The effect of glucose and mental stress on cutaneous microvascular endothelial function.Noninvasive assessment of endothelial activity in patients with peripheral arterial disease and cardiovascular risk factors.Cholesterol lowering and coronary artery disease: mechanisms of risk reduction.Persistent weight loss with a non-invasive novel medical device to change eating behaviour in obese individuals with high-risk cardiovascular risk profile.Endothelial dysfunction as a target for prevention of cardiovascular disease.In vivo detection of endothelium dependent and independent pulmonary artery relaxation in childrenArteriographic view of treatment to achieve regression of coronary atherosclerosis and to prevent plaque disruption and clinical cardiovascular events.Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol.Telomere length and replicative aging in human vascular tissues.Endothelial Dysfunction Markers in Low Cardiovascular Risk Individuals: Comparison of Males and Females.The assessment of endothelial function in the cardiac catheterization laboratory in patients with risk factors for atherosclerotic coronary artery disease.NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties.Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications.Evaluation of bioavailability of nitric oxide in coronary circulation by direct measurement of plasma nitric oxide concentrationVascular imaging: changing the face of cardiovascular research.Endothelium-dependent vasodilation in hypertension: a review.Cholinergic responses of ophthalmic arteries in M3 and M5 muscarinic acetylcholine receptor knockout mice.Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study.Testing for endothelial dysfunction.Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.Endothelial function as a therapeutic target in coronary artery disease.Treating ambulatory ischemia in coronary disease by manipulating the cell biology of atherosclerosis.Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level.Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits.
P2860
Q24650963-564F78B5-56DA-420E-A491-275D21058E92Q24680127-BAF6E204-EB6C-4ACC-9C17-5B162116A076Q26801781-48EBD8A7-AC7E-408B-9560-0096CBD244C6Q28175811-72B98355-F596-4F5D-9A03-1C31B78A2E9CQ28195411-10F0B517-A379-4C0D-85EA-0F27E1D94616Q28377505-8E1293B8-161F-494B-8F73-8058F945390AQ28390251-98A7D932-CCF8-4C45-8766-A76189831EAAQ28510643-4A9A00C3-167F-42CD-9307-8841C6D70DD9Q30441386-CE51106B-E3B0-4BF7-805F-2B7BD57E1145Q30498448-8F78CA27-EDDD-46F6-BEF4-E9E835A3BE35Q30513467-9AE03083-7C70-4A28-A2DD-3E0B74D4D9DEQ30535389-240F9722-3AF3-41EE-9525-B7BC69DCEEB8Q30783223-64E6DFED-1E6F-4722-A5BE-9ACFA99BCA82Q30813656-5CC255C4-7A49-4336-8E19-A495A9CAA98CQ30829627-CF4EE922-B0DD-44D4-840D-B4227D85509BQ32051383-CA49D3E2-7D73-4DED-A44C-92A840131203Q33216708-531ED7AD-A4B2-4433-8C98-10AA1BA3495BQ33301912-B6326109-1C44-4502-B71E-A8C560F0DBB5Q33538129-F743D17F-2419-4A71-B039-AAE2D794F77CQ33557930-9C333944-3FE7-48F0-8483-EF0C6AE02045Q33610670-FEA047B5-7664-41AB-980F-7DAFF16ACA8DQ33612593-F046287D-243D-45E1-B157-9763004532C8Q33613217-FC3E04FC-DFEB-424D-80D8-D64F9D42C0D3Q33745065-6AC3971E-55C4-4868-83D1-38FD6D633419Q33763501-CEC6043C-DEE2-4B26-9E74-36F462DC166DQ33801124-BEEB13CB-2778-4D07-ADA1-FB0A65B46AA0Q33802865-EAA962F7-4C24-414C-AFFA-725999B674F5Q33896104-044498AB-DFFF-453D-9F49-D02667FC61E5Q33901576-DB094FCC-BD25-40A2-9DCF-6B04F0454DC5Q33913918-DAA2FB36-3241-4EE9-B9F6-2A3467577B97Q33915434-7E26AD6A-597B-43E5-8D19-6C7AEDF26F54Q33942959-06D46B43-5A58-4A39-8723-C7BCA53400E4Q33950667-9D1E7DAA-0AC0-4FE4-9688-FDAE5F9ADB24Q33967744-EA758CDC-BF15-4FDF-821D-D34F558D333FQ34008359-E7588E03-B64A-477D-9205-3593EEA2006EQ34086042-F73771DF-30BE-497E-922B-27B738F0AEB0Q34107475-25C6363A-8673-4E31-ADA8-95C10D048081Q34107489-1C72794D-017A-4E05-86EB-7558FC0AA6BFQ34118495-B517B0A5-AE2A-4DBE-9267-12944BD1582BQ34127841-03A87235-3C0D-4337-A41C-F6D62592B6DE
P2860
Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Coronary vasomotor response to ...... s for coronary artery disease.
@en
type
label
Coronary vasomotor response to ...... s for coronary artery disease.
@en
prefLabel
Coronary vasomotor response to ...... s for coronary artery disease.
@en
P2093
P356
P1433
P1476
Coronary vasomotor response to ...... s for coronary artery disease.
@en
P2093
McLenachan JM
Treasure CB
Vekshtein VI
P304
P356
10.1161/01.CIR.81.2.491
P407
P577
1990-02-01T00:00:00Z